18:04:52 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-08 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-14 Kvartalsrapport 2024-Q1
2024-04-29 Ordinarie utdelning OMDA 0.48 NOK
2024-04-25 Årsstämma 2024
2024-03-01 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-09-26 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-12 Kvartalsrapport 2023-Q1
2023-04-28 Ordinarie utdelning OMDA 0.00 NOK
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-11-30 Kvartalsrapport 2022-Q3
2022-10-03 Extra Bolagsstämma 2022
2022-08-30 Kvartalsrapport 2022-Q2
2022-05-20 Ordinarie utdelning OMDA 0.00 NOK
2022-05-19 Kvartalsrapport 2022-Q1
2022-05-19 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-05-26 Kvartalsrapport 2021-Q1
2021-05-07 Ordinarie utdelning OMDA 0.00 NOK
2021-05-06 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-12-11 Extra Bolagsstämma 2020
2020-11-27 Kvartalsrapport 2020-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
OMDA är verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av digitala plattformar för vården. Programvaran är egenutvecklad och används huvudsakligen för analys och uppföljning av olika områden inom sjukvården. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Verksamhet innehas på global nivå med störst närvaro inom den europeiska marknaden.
2024-03-01 07:00:00
Oslo, Norway, 1 March 2024: Today, Omda AS ("Omda"), a leading provider of
specialised software for healthcare and emergency response, published its
results for the fourth quarter of 2023.

Omda continues its profitable growth and reported revenues of NOK 109 million
for Q4-23, a 11% increase over Q4-22. The company delivered MNOK 415 for the
year, 12% more than 2022.

Omda CEO Sverre Flatby emphasises the growth: "We exceed our organic growth
targets, beating the NOK 400 million target for the year. And most importantly,
78% of total 2023 revenue is recurring and stems from long-term contracts which
generate a diversified revenue stream with minimal customer churn."

The EBITDA margin was 19% for the quarter compared to -21% in Q4-22.

"Our margin-improvement program and decentralisation now show results. With 23%
EBITDA in 2H-23 compared to 8% in 1H-23 we expect EBITDA-margin improvement to
continue in 2024," Flatby concludes.

Highlights from the report:
o Q4-23 total income 109 MNOK vs 98 MNOK in Q4-22
o Full-year income 415 MNOK, a 12% increase over 2022
o Reported EBITDA was 20 MNOK resulting in a 19% EBITDA margin for Q4-23,
compared to -21% in Q4-22
o Recurring revenue 75% of total sales, same as in Q4-22
o Q4-23 organic growth of 10% in local currency vs Q4-22 (15% in NOK)
o Full-year organic growth of 9.5% in local currency (13% in NOK)
o Completed a new bond issue of 500 MNOK, with an additional tap issue of 500
MNOK


For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@omda.com

About Omda
Omda is the leading provider of specialised software for healthcare and
emergency services in the Nordics with a growing presence in Europe, North
America and the Pacific region. The company has more than 500 customers in 27
countries and employs almost 300 dedicated specialists. Our highly specialised
healthcare solutions empower medical professionals and emergency responders,
enabling them to know more and work smarter. With a focus on user-centric
design, value-driven development and close working relationships with customers,
Omda delivers solutions that enhance patient safety and improve healthcare
outcomes.

For more information, visit www.omda.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH